Safety and Feasibility of Irradiation and Nivolumab in Esophageal Cancer (INEC)
Safety and Feasibility of Irradiation and Nivolumab in Esophageal Cancer (INEC)
Active, not recruiting · NCT03544736 · Registry updated 2023-03-22Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety and Feasibility of Irradiation and Nivolumab in Esophageal Cancer (INEC) | Digestive System Diseases, Digestive System Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Neoplasms by Site, digestive system disorder, digestive system neoplasm, esophageal cancer, esophageal disorder, neoplasm | Active, not recruiting | Phase 1 / Phase 2 | 2023-03-22 | NCT03544736 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Bristol-Myers Squibb | 422 |
| Oslo University Hospital | 327 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Oslo University Hospital | Oslo | Norway | 37 |